MDP Group is partnering a global CRO on a Phase XXX study in Plaque Psoriasis

X October 2017 – MDP Group is partnering a global CRO on a Phase XXX study in Plaque Psoriasis. The study is open to both women and men from >18 years. Patients will be enrolled at MDP Group sites in Saint Petersburg.